Enlivex Therapeutics Ltd - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring peer group for Enlivex Therapeutics Ltd are shownin the table. This page contains a zero-cost Sustainability analysis covering Enlivex Therapeutics Ltd. This SDG score for Enlivex Therapeutics Ltd represents its reporting of the United Nations SDGs.
Enlivex Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 5.3, social score of 4.8 and governance score of 2.0.
4.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | Enlivex Therapeutics Ltd | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Enlivex Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Enlivex Therapeutics Ltd disclose current and historical energy intensity?
Does Enlivex Therapeutics Ltd report the average age of the workforce?
Does Enlivex Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Does Enlivex Therapeutics Ltd disclose its ethnicity pay gap?
Does Enlivex Therapeutics Ltd disclose cybersecurity risks?
Does Enlivex Therapeutics Ltd offer flexible work?
Does Enlivex Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Enlivex Therapeutics Ltd disclose the number of employees in R&D functions?
Does Enlivex Therapeutics Ltd conduct supply chain audits?
Does Enlivex Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Enlivex Therapeutics Ltd conduct 360 degree staff reviews?
Does Enlivex Therapeutics Ltd disclose the individual responsible for D&I?
Does Enlivex Therapeutics Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Enlivex Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Does Enlivex Therapeutics Ltd disclose water use targets?
Does Enlivex Therapeutics Ltd have careers partnerships with academic institutions?
Did Enlivex Therapeutics Ltd have a product recall in the last two years?
Does Enlivex Therapeutics Ltd disclose incidents of discrimination?
Does Enlivex Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Has Enlivex Therapeutics Ltd issued a profit warning in the past 24 months?
Does Enlivex Therapeutics Ltd disclose parental leave metrics?
Does Enlivex Therapeutics Ltd disclose climate scenario or pathway analysis?
Does Enlivex Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Enlivex Therapeutics Ltd disclose the pay ratio of women to men?
Does Enlivex Therapeutics Ltd support suppliers with sustainability related research and development?
Does Enlivex Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Enlivex Therapeutics Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Enlivex Therapeutics Ltd involved in embryonic stem cell research?
Does Enlivex Therapeutics Ltd disclose GHG and Air Emissions intensity?
Does Enlivex Therapeutics Ltd disclose its waste policy?
Does Enlivex Therapeutics Ltd report according to TCFD requirements?
Does Enlivex Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Enlivex Therapeutics Ltd disclose energy use targets?
Does Enlivex Therapeutics Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Enlivex Therapeutics Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Enlivex Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.